×

Azaindole derivatives, process for their preparation, and their use as antitumor agents

  • US 6,335,342 B1
  • Filed: 06/19/2000
  • Issued: 01/01/2002
  • Est. Priority Date: 06/19/2000
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method for treating cell proliferative disorders associated with an altered cell dependent kinase activity, by administering to a mammal in need thereof an effective amount of a 1H-pyrrolo[2,3-b]pyridine represented by formula (I):

  • embedded imagewhereinR is a hydrogen or halogen atom or a group selected from —

    CN, —

    OH, —

    OCOR4, —

    (CH2)nNH2, —

    (CH2)nNHR4, —

    (CH2)nNHCOR4, —

    (CH2)nNHCONR4R5, —

    (CH2)nNHCOOR4, or —

    (CH2)nNHSO2R4, wherein n is either 0 or 1, R4 and R5 are, independently from each other, hydrogen or an optionally substituted group selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, cycloalkylalkenyl, cycloalkylalkynyl, heterocyclyl, heterocyclylalkyl, heterocyclylalkenyl, heterocyclylalkynyl, aryl, arylalkyl, arylalkenyl, arylalkynyl or, taken together with the nitrogen atom to which they are bonded, form an optionally substituted heterocyclyl group;

    R1 is hydrogen or an optionally substituted alkyl group;

    R2 is an optionally substituted group selected from alkyl or aryl;

    R3 is hydrogen or a group selected from —

    CONR4R5, —

    COOR4, —

    CONHOR4, —

    SO2NHR4, alkylsulphonylaminocarbonyl or perfluorinated alkylsulphonylaminocarbonyl;

    wherein R4 and R5 have the above reported meanings;

    or a pharmaceutically acceptable salt thereof.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×